The effect of Biktarvy (B/F/ <scp>TAF</scp> ) on whole‐body insulin sensitivity, lipid and endocrine profile in healthy volunteers
Treatment with Biktarvy for 28 days was not associated with a statistically significant impact on total body insulin sensitivity as measured using a hyper-insulinaemic-euglycaemic clamp method. However, long-term data on the metabolic effects of Biktarvy are needed.
Authors
- Joseph Heskin (ORCID: https://orcid.org/0000-0002-4460-8363)
- Graeme Moyle (ORCID: https://orcid.org/0000-0002-2395-3774)
- Ana Milinkovic (ORCID: https://orcid.org/0000-0002-7732-9168)
- Paola Marchesani
- Roya Movahedi
- Perrine Gridel
- Ruth Byrne
- Marta Boffito
- Krestine Elecito
- Sujin Kang
Institutions
- Chelsea and Westminster Hospital NHS Foundation Trust (GB)
- Imperial College London (GB)
Publication Details
- Journal
- HIV Medicine
- Published
- 2026-02-18
- DOI
- https://doi.org/10.1111/hiv.70208
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00